Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
17.82
+0.53 (3.07%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Beta Bionics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Beta Bionics stock has a consensus rating of "Buy" and an average price target of $19.73. The average 1-year stock price forecast is 10.72% higher than the current stock price, while the lowest is $13 (-27.05%) and the highest is $32 (+79.57%).
Price Target: $19.73 (+10.72%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Beta Bionics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 7 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Reiterates $17 → $19 | Buy | Reiterates | $17 → $19 | +6.62% | Jul 15, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $18 → $22 | Buy | Maintains | $18 → $22 | +23.46% | Jul 13, 2026 |
| Lake Street | Lake Street | Buy Reiterates $20 | Buy | Reiterates | $20 | +12.23% | Jun 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $20 | Buy | Reiterates | $20 | +12.23% | Jun 22, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $11 → $13 | Hold | Reiterates | $11 → $13 | -27.05% | May 22, 2026 |
Financial Forecast
Revenue This Year
133.31M
from 100.25M
Increased by 32.98%
Revenue Next Year
179.55M
from 133.31M
Increased by 34.69%
EPS This Year
-2.11
from -1.38
EPS Next Year
-2.39
from -2.11
EPS and Forward PE are based on non-GAAP adjusted numbers.